New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
08:40 EDTMDXGMiMedx EpiFix allograft awarded coverage by HCSC
MiMedx Group announced that Health Care Services Corporation, HCSC, has confirmed that the company's EpiFix allograft has been awarded reimbursement coverage. HCSC has approved the reimbursement of EpiFix for the indications as prescribed by the physician, including wound care, soft tissue replacement or repairs in burns, cardiovascular applications, treatment of ocular surfaces, and the application as a surgical barrier in knee or spine surgeries. The company also reported that its EpiFix allograft currently has reimbursement approval from 12 state Medicaid Programs.
News For MDXG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
07:45 EDTMDXGMiMedx backs FY15 revenue view $180M-$190M, consensus $187.44M
Sees FY15 operating margin 12%-14%.
07:44 EDTMDXGMiMedx sees Q3 revenue $47M-$50M, consensus $48.68M
Sees Q3 operating profit 13%-15%.
07:43 EDTMDXGMiMedx reports Q2 EPS 5c, consensus 5c
Reports Q2 revenue $45.7M, consensus $44.99M.
July 29, 2015
10:00 EDTMDXGOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:28 EDTMDXGMiMedx downgraded to Buy from Strong Buy at Needham
Needham downgraded MiMedx to Buy from Strong Buy with a $15 price target. The firm said MiMedx faces more difficult comps the rest of the year and downgraded shares based on limited upside to consensus estimates and valuation.
July 17, 2015
10:05 EDTMDXGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:25 EDTMDXGBrean says MiMedx becoming regenerative medicine company, starts with buy
Subscribe for More Information
05:31 EDTMDXGMiMedx initiated with a Buy at Brean Capital
Target $16.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use